Francois Lilienthal

Dr. Lilienthal is an accomplished global biopharmaceutical leader and trained physician with over 20 years of experience leading the commercialization of novel medicines and driving multi-billion-dollar growth across diversified portfolios and businesses. Dr. Lilienthal held several global leadership roles at Merck, leading successful global brand launches for HIV and Hepatitis C. He oversaw the creation of commercial processes integrating new capabilities such as digital technologies, advanced data analytics and global partnerships into clinical development. Dr. Lilienthal served as Executive Director and U.S. Brand Leader at Tibotec, where he launched three innovative HIV brands and drove the launch of Prezista, which achieved $800M in annual revenues at its peak. Dr. Lilienthal has also served as Executive Director and Global Marketing Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson and Director and Global Marketing Leader at Bristol Myers Squibb. Dr. Lilienthal earned his MD and MA from the University of Paris and holds an MBA in Marketing and Management from the University of Pennsylvania.